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Abstract The umbilical artery lumen closes rapidly at birth, preventing neonatal blood loss,
whereas the umbilical vein remains patent longer. Here, analysis of umbilical cords from humans
and other mammals identified differential arterial-venous proteoglycan dynamics as a determinant
of these contrasting vascular responses. The umbilical artery, but not the vein, has an inner layer
enriched in the hydrated proteoglycan aggrecan, external to which lie contraction-primed smooth
muscle cells (SMC). At birth, SMC contraction drives inner layer buckling and centripetal
displacement to occlude the arterial lumen, a mechanism revealed by biomechanical observations
and confirmed by computational analyses. This vascular dimorphism arises from spatially regulated
proteoglycan expression and breakdown. Mice lacking aggrecan or the metalloprotease ADAMTS1,
which degrades proteoglycans, demonstrate their opposing roles in umbilical vascular dimorphism,
including effects on SMC differentiation. Umbilical vessel dimorphism is conserved in mammals,
suggesting that differential proteoglycan dynamics and inner layer buckling were positively
selected during evolution.
Introduction
The umbilical cord, typically containing two arteries and one vein in humans, is a crucial fetal struc-
ture in placental mammals. Umbilical arteries carry fetal blood to the placental vascular bed, whereas
the umbilical vein returns oxygenated blood to the fetus. Neonatal respiration at birth renders the
maternal oxygen supply redundant. Umbilical arteries commence closure rapidly after delivery of the
newborn whereas the veins remain open longer. The cord is routinely clamped following delivery
and divided between the clamps in modern obstetric practice. Timing of cord clamping after birth,
whether early or late, is extensively debated (Niermeyer, 2015; Tarnow-Mordi et al., 2017). A
recent recommendation suggested clamping no earlier than 30–60 s after birth to facilitate the
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placental transfusion (TACoOaG, 2017). Although the necessity of clamping is rarely questioned, it
appears to be a modern practice (Downey and Bewley, 2012). Cord clamping is rarely practiced in
domesticated animals and certainly not in wild animals, yet all current mammalian species have sur-
vived evolutionarily. We hypothesized that intrinsic design characteristics of mammalian umbilical
arteries prevent blood loss at birth without clamping.
Prior histological work revealed that umbilical arteries have a bilaminar structure (Meyer et al.,
1978) but lack elastic lamellae, which endow large arteries with resilience during cyclic loading
(Wagenseil and Mecham, 2009). However, the molecular mechanism underlying the bilayered struc-
ture and its relationship to arterial occlusion remains obscure. Here, we used a multi-disciplinary
approach integrating a variety of morphologic approaches with mechanical testing, computational
analysis and mouse mutants to demonstrate the molecular and biomechanical basis for rapid umbili-
cal artery closure. The findings emphasize the dual importance of extracellular matrix proteoglycans
in regulation of cell differentiation and conferment of desirable tissue mechanical characteristics.
Results
The umbilical artery has a bilaminar wall
Three-dimensional imaging of term human umbilical cords, using synchrotron-based phase contrast
micro-CT with effective pixel size 1.63  1.63 mm2 (Norvik et al., 2020) and histology, identified a
much thicker tunica media (TM) in the umbilical artery than in the vein, with a visibly different struc-
ture (Figure 1a–c, Figure 1—figure supplement 1a–c, Figure 1—videos 1, 2). Most umbilical arter-
ies were occluded at birth independent of delivery method or cord region analyzed, whereas
umbilical veins remained patent (Figure 1b, Figure 1—figure supplement 1b). Smooth muscle cell
(SMC) markers showed similar staining intensities within inner and outer TM of the umbilical arteries
and TM of the vein with alternating layers of longitudinal and circumferentially oriented SMCs (Fig-
ure 1—figure supplement 1c,d). The veins showed fewer layers of SMCs compared to the arteries
(Figure 1—figure supplement 1c,d).
Alcian blue, which binds sulfated glycosaminoglycans (GAGs), intensely stained the inner layer of
the bilayered arterial TM but only the innermost three to four cell layers of the venous TM
(Figure 1c). SMCs in this GAG-rich region of the arteries were radially oriented and round, with
nuclear-localized Sox9, a chondrogenic factor (Figure 1—figure supplement 1e; Ng et al., 1997).
The distribution of chondroitin sulfate (CS) coincided with Alcian blue staining (Figure 1c–d, Fig-
ure 1—figure supplement 1e), whereas heparan sulfate was more abundant in the outer arterial TM
(Figure 1d), suggesting that the inner TM was enriched in CS-proteoglycans (CSPGs). RNA microar-
ray data from matched human umbilical arteries and veins showed, among many differentially
expressed genes (Figure 1e, Figure 1—figure supplement 2, Sup. array data-1), arterial prevalence
of mRNAs for ACAN and VCAN encoding CSPGs bearing the most CS-chains, aggrecan and versi-
can, respectively (Figure 1e). Microarray analysis of the inner versus outer arterial TM identified
stronger ACAN and VCAN expression in the inner TM, among other differences (Figure 1e, Fig-
ure 1—figure supplement 3, Sup. array data-2). RNA in situ hybridization (RNA-ISH) localized
strong ACAN and VCAN expression in inner arterial TM SMC, and immunostaining showed versican
and aggrecan core proteins in a similar distribution as alcian blue and anti-CS staining (Figure 1c,d,
f). Versican is a well-characterized vascular component (Wight and Merrilees, 2004), and aggrecan,
which is known as a cartilage and neural proteoglycan (Lauing et al., 2014; Schwartz and Domo-
wicz, 2014), is emerging as a significant CSPG in vascular disease (reviewed in Koch et al., 2020).
ADAMTS proteoglycanases are differentially expressed in the umbilical
artery and vein
Aggrecan and versican are proteolytically cleaved by ADAMTS1, 4, 5, and 9 (Dancevic et al., 2016).
ADAMTS1 and ADAMTS4 mRNAs had higher levels in the venous wall in microarrays (Figure 1e,
Sup. Array data-1), and RNA-ISH demonstrated stronger expression of ADAMTS1, ADAMTS4,
ADAMTS5, and ADAMTS9 in the veins (Figure 2a). ADAMTS1 was the most strongly expressed,
localizing to venous endothelium and TM, with stronger umbilical artery expression seen in the outer
than inner TM (Figure 2a). ADAMTS9 was similarly expressed as ADAMTS1, whereas ADAMTS4 and
ADAMTS5 mRNAs were restricted to umbilical vein endothelium and some venous SMC (Figure 2a).
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Figure 1. Dimorphism of the human umbilical artery and vein. (a) Synchrotron imaging of umbilical vessels at birth illustrates a bilayered arterial wall
comprising an inner buckled tunica media (TM) (red) and outer TM (purple) but no distinct inner layer or buckling in the vein. X-Y and Y-Z image planes
are indicated by red dashed lines (n = 3 umbilical cords). (b) Quantitation of luminal cross-sectional area at birth shows that the umbilical arteries are
occluded whereas the veins remain patent (top) and have significantly thicker walls (bottom) (n = 20 cords, error bars indicate mean ± S.E.M., whiskers
Figure 1 continued on next page
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Neo-epitope antibodies detecting ADAMTS-cleaved aggrecan and versican (anti-NITEGE and anti-
DPEAAE, respectively) (Lark et al., 1995; Sandy et al., 1992; Sandy et al., 2001) showed strong
staining throughout the venous TM and in the outer arterial TM, but not the inner arterial TM
(Figure 2b). Thus, proteoglycan accumulation in the inner TM of the umbilical artery may result from
higher ACAN and VCAN expression and less proteolysis. In contrast, lower ACAN and VCAN
expression and greater ADAMTS levels within the umbilical vein may preclude proteoglycan
accumulation.
ADAMTS-mediated differential proteoglycan abundance in the umbilical
artery and vein is evolutionarily conserved
We postulated that abundant hydrated proteoglycans in the inner arterial TM provided compressive
stiffness that could not only prevent kinking and premature occlusion but could potentially facilitate
rapid umbilical artery closure at birth. If so, similar adaptations should be present in other mammals.
Analysis of umbilical cords from nine large primate and non-primate mammals disclosed similar
dimorphism, namely, umbilical arteries were occluded and had thicker walls with similar infolding of
the inner arterial TM (Figure 3a) and strong Alcian blue and CS-staining, contrasting with veins
(Figure 3a,b). Anti-aggrecan and anti-NITEGE stained several animal species, confirming aggrecan
abundance in the inner arterial TM and robust aggrecan cleavage resulting from ADAMTS protease
activity in the outer TM of the artery and the TM of the vein (Figure 3c–d, Figure 3—figure supple-
ment 1).
Aggrecan and ADAMTS1 are necessary for normal umbilical cord
morphogenesis
Mouse umbilical cords also demonstrated vascular dimorphism (Figure 4a), suggesting that geneti-
cally modified mice would provide mechanistic insights into proteoglycan dynamics and its impact.
Aggrecan and versican immunofluorescence showed strong staining in the mouse umbilical artery
inner TM and adventitia, with weaker staining in the veins (Figure 4b). Acan, Vcan and
Adamts1,4,5,9 RNA-ISH at early (E12.5) and late (E18.5) gestational stages showed that Acan and
Vcan were strongly expressed in the umbilical arteries (Figure 4—figure supplement 1a). Adamts1
was the most highly expressed proteoglycanase in the mouse umbilical vein just prior to parturition
(E18.5) (Figure 4—figure supplement 1a), evidenced by strong b-gal staining in venous TM, adven-
titia and endothelium; the inner umbilical artery TM and endothelium of Adamts1lacZ/+ embryos
lacked b-gal staining (Figure 4c). Although Adamts9 mutant embryos were previously observed to
have short umbilical cords, abnormal umbilical artery development, and to die by 14.5 days of gesta-
tion (Nandadasa et al., 2015), umbilical cord development was not previously investigated in
Figure 1 continued
indicate minimum and maximum values. ***, p<0.001). (c) Alcian blue, eosin (pink) and nuclear fast red staining of umbilical vessel cross-sections shows
a proteoglycan-rich (blue) inner TM in the umbilical artery but not the vein. Quantified staining intensity is shown on the right (n = 6 umbilical cords,
whiskers indicate minimum and maximum values, ***, p<0.001). (d) Chondroitin sulfate (CS), heparan sulfate (HS), aggrecan and versican
immunofluorescence (n = 4 cords for each antibody) showing that CS staining corresponds with aggrecan and versican staining and alcian blue in (c). (e)
Volcano plots illustrating differential gene expression between human umbilical artery (red) and vein (green) (top, n = 4 umbilical arteries and veins) and
differential gene expression between human umbilical artery inner TM (red) and the outer TM (green) (bottom, n = 2). (f) RNA in situ hybridization
shows robust ACAN and VCAN expression (red signal) in the inner artery TM and weak expression in the vein (n = 3 umbilical cords for each in situ
probe). * marks the vessel lumen. Brackets in c,d,f mark the TM. Wj, Wharton’s jelly. Scale bars = 100 mm in c,d,f.
The online version of this article includes the following video and figure supplement(s) for figure 1:
Figure supplement 1. Morphological and cellular characteristics of the human umbilical arteries and veins at birth.
Figure supplement 2. Transcriptome comparison and pathway analysis of differences in the human umbilical artery and vein.
Figure supplement 3. Transcriptome comparison and pathway analysis of differences in the human inner umbilical artery tunica media (TM) vs the
outer tunica media.
Figure 1—video 1. Synchrotron image stack of an umbilical artery.
https://elifesciences.org/articles/60683#fig1video1
Figure 1—video 2. Synchrotron image stack of an umbilical vein.
https://elifesciences.org/articles/60683#fig1video2
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Figure 2. ADAMTS proteoglycanases are highly expressed and active in the human umbilical vein. (a) RNA in situ hybridization shows robust ADAMTS1
and ADAMTS9 expression in umbilical vein endothelium and tunica media (TM) and in outer arterial TM. Robust ADAMTS4 and ADAMTS5 expression
was confined to the venous endothelium, with moderate ADAMTS4 expression and minimal ADAMTS5 expression in SMC (n = 3 umbilical cords for
each probe). (b) ADAMTS-cleaved aggrecan (anti-NITEGE, red) and versican (anti-DPEAAE, red) both showed strong ADAMTS proteolytic activity
Figure 2 continued on next page
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mutants of the two genes implicated here as potentially critical for umbilical cord vascular dimor-
phism, Acan and Adamts1.
The Adamts1-/- mutant is an insertion of an IRES lacZ-bearing cassette into intron 1 of the gene
(Oller et al., 2017). This insertion reveals Adamts1 expression via staining for ß-galactosidase activ-
ity, and eliminated expression from the targeted allele but in its hemizygous state, the insertion led
to reduction in both mRNA and protein (Oller et al., 2017). The Acancmd-Bc allele is a spontaneous
mutation found in a BALB/C colony (Bell et al., 1986) and resulted from deletion of exon 2 through
exon 18 (Krueger et al., 1999). Acan-/- embryos do not survive past birth (Krueger et al., 1999;
Lauing et al., 2014) and few surviving Adamts1-/- mice were identified at the time of weaning
(Oller et al., 2017). Acan mutants are thought to succumb to respiratory failure resulting from soft
tracheal cartilages and ribs, whereas the cause of Adamts1-/- lethality is unknown. At E18.5, Acan-/-
and Adamts1-/- mutants each had significantly short umbilical cords (Figure 4d) demonstrating their
requirement for proper umbilical cord development. Umbilical cord histology showed thinner vascu-
lar walls in Acan-/- umbilical vessels, and conversely, thicker vascular walls in Adamts1-/- umbilical ves-
sels (Figure 4e–g). At earlier developmental stages (E12.5 to E14.5), lack of aggrecan did not affect
either umbilical cord length or circumferential SMC reorientation (Figure 4—figure supplement 1b–
d), which occurs around E13.5 and is defective in Adamts9 mutants (Nandadasa et al., 2015). Fur-
thermore, lack of aggrecan did not impair the survival of mouse embryos until parturition, since
Acan-/- embryos were observed at the expected Mendelian ratio at E18.5 (Figure 4—figure supple-
ment 1c). Thus, Acan and Adamts1 appear to be involved in umbilical vessel development from
early gestation, but their functions manifest near parturition.
Contrasting SMC phenotypes in Acan and Adamts1-deficient umbilical
cords
The arterial and venous lumina were smaller in Adamts1-/- mice relative to wild-type, indicating that
their thicker vascular walls compromised luminal diameter, and larger in Acan-/- mice (Figure 4e–g).
Phospho-histone H3 staining revealed fewer proliferating cells in Acan-/- umbilical cords at E18.5
(Figure 4h). Immunostaining for SMC markers smooth muscle a-actin (SMA), smooth muscle myosin
heavy chain (SMMHC), and phosphorylated myosin light chain (pMLC) showed weaker intensity in
Acan-/- umbilical arteries compared to wild-type (Figure 5a,b). In contrast, Adamts1-/- umbilical ves-
sels showed stronger SMA, SMMHC and pMLC staining than wild-type littermates and apparent
overgrowth of the arterial and venous walls (Figure 5c). Intriguingly, endomucin, a venous endothe-
lium-specific marker (dela Paz and D’Amore, 2009), also stained Adamts1-/- umbilical arterial endo-
thelium (Figure 5c) suggesting that ADAMTS1 may have a role in specifying artery/vein identity.
Immunostaining of E17.5 Adamts1-/- umbilical cords indicated a crucial role for ADAMTS1 in regulat-
ing proteoglycan dynamics in the mouse umbilical cord. Specifically, we observed robust aggrecan
and versican accumulation in the Adamts1-/- umbilical vein and in the outer TM of the Adamts1-/-
umbilical artery (Figure 6a–d) with severe reduction of aggrecan and versican neo-epitope staining
(Figure 6a–d).
Differential SMC contraction in the bilayered umbilical arteries
Despite uniform staining with SMC markers in human umbilical vascular SMC, co-staining with ser-
ine20-phosphorylated myosin light chain (pMLC) marking contractile SMCs (Dougherty et al., 2014)
revealed that human umbilical arteries had more contractile SMCs than the vein, predominantly in
the outer TM (Figure 7a,b). This suggests that outer umbilical artery SMCs are principally responsive
to vasoconstriction stimuli at birth, whereas inner SMCs are relatively non-contractile. We hypothe-
sized that an outer ring of contracting SMCs could drive the CSPG-rich inner arterial TM centripe-
tally, occluding the lumen, and addressed this possibility initially using ex vivo biomechanical testing
of late-gestation mouse umbilical vessels (Figure 7c, Figure 7—figure supplement 1). Mouse umbil-
ical arteries had a smaller lumen, as expected at E18.5, and deformed less when loaded
Figure 2 continued
throughout the venous wall and the outer artery TM. Unlike aggrecan, extensive versican proteolysis is seen in the arterial intima and sub-intima (n = 4
umbilical cords for each antibody). Wj, Wharton’s jelly. The brackets mark TM boundaries. Scale bars in a-b = 100 mm.
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mechanically, namely, they exhibited lower (circumferential) distensibility and especially (axial) exten-
sibility under passive conditions compared to the umbilical veins (Figure 7—figure supplement 1a–
d). Umbilical arteries constricted significantly (30–50% reduction in measured outer diameter at 25
mm Hg fixed pressure), causing complete luminal occlusion verified by optical coherence (OCT)
Figure 3. Aggrecan enrichment in the inner umbilical artery tunica media (TM) and its proteolysis in the umbilical vein is a characteristic of large
mammals. (a) Alcian blue-eosin staining of umbilical cord sections shows proteoglycan enrichment (blue) in the inner arterial tunica media (TM). The
elephant umbilical vein was unavailable. (b) Anti-CS immunofluorescence (7D4, green) shows enrichment in the inner arterial TM. Bonobo cords lacked
7D4 reactivity. (c,d) Aggrecan and anti-NITEGE immunostaining from reactive species showed aggrecan enrichment in the inner arterial TM and
aggrecan proteolysis in the vein and outer artery TM. n = 3 for Gazelle and n = 1 for other mammals. Triplicate sections were stained from each animal
cord. Scale bars = 100 mm and 200 mm. * indicates the vessel lumen.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Aggrecan cleavage site conservation in mammals.
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imaging, which was not observed in the umbilical veins (Figure 7c). Cross-sectional area measure-
ments at fixed lengths revealed wall volume reductions during vasoconstriction (Figure 7—figure
supplement 1e), less in the umbilical vein (~35%) than the umbilical artery (~50%), suggesting fluid
exudation from the wall under forceful SMC contraction.
Computational modeling of arterial occlusion
These biomechanical tests of mouse umbilical cords, together with histological and immunostaining
findings from human cords, motivated and informed a novel computational model of the umbilical
artery incorporating its complex bilayered, multi-constituent structure (GAG-rich inner layer and con-
tractile SMC-rich outer layer; Figure 7d) and multiaxial mechanical loading: axial extension, luminal
pressurization, active contraction by SMCs, and intramural swelling of the inner layer that regulates
tissue volume locally based on GAG content. Nonlinear regression of biaxial mechanical data from
passive tests of the murine vessels identified best-fit values of the material parameters in the base-
line constitutive model, while data from active contraction studies guided the selection of the associ-
ated active constitutive parameters (Table 1). Model-based parametric studies examined
combinations of different levels of GAG-driven swelling and SMC-generated active stress to identify
their roles in umbilical artery closure at different levels of fixed luminal pressure. Increasing inner
layer swelling in the absence of active outer layer stress narrowed the lumen at a fixed pressure, as
expected given the constraining effect of the outer stiff passive matrix (Figure 7—figure supple-
ment 2a). This trend reversed in the presence of active stresses, with increasing inner layer GAGs
able to oppose vasoconstriction if overall wall volume remained constant (Figure 7—figure supple-
ment 2b). Thus, increased inner layer swelling attenuates the ability of SMC contraction to prema-
turely reduce luminal radius, as revealed by varying the active stress parametrically for different fixed
values of inner layer swelling. Importantly, the model predicted a sharp transition from a widely pat-
ent to a narrowed lumen due to small changes in active stress at lower values of swelling whereas
radius changes were more gradual at higher values of swelling (Figure 7—figure supplement 2b).
This transition, at which a decrease in volume of the inner layer associates with larger or smaller lumi-
nal radii for values of active stress below or above Tact ffi 50 kPa (a key parameter of active stress
generation) appears to be close to the in vivo value. Hence, consistent with ex vivo findings (Fig-
ure 7—figure supplement 1), it appears that inner layer volume loss during increased SMC contrac-
tion aids vessel narrowing. Regardless, the inner radius reached nearly constant values for increasing
levels of active stress (Figure 7—figure supplement 2b). Thus, contraction alone is insufficient to
occlude the vessel.
Folding of the arterial inner layer is necessary for vascular occlusion
Given the consistent histological finding of inner arterial TM infolding following birth, we modeled
the biomechanics of superimposed inner layer buckling in the bilayered arterial model. Buckling can
release energy stored in the inner layer during vasoconstriction-induced compression, thereby
reducing the structural stiffness and resistance to SMC contraction. This analysis parametrically con-
sidered possible perturbations to the cylindrical geometry achieved at various levels of fixed luminal
pressure and different values of swelling and actively generated wall stress. Examining the influence
of the number of inner layer folds for different values of swelling disclosed higher inward buckling
probability with more folds (Figure 7d). Since Tact needed to cause buckling tended to plateau at 7
folds, we used 7 folds subsequently for illustrative purposes. Tact needed to cause buckling
decreased for a more swollen inner layer Figure (7dFigure 7—figure supplement 2c) and increased
exponentially with inner layer volume loss. This finding was likely due to the less negative values of
circumferential wall stress in the inner layer occurring with shrinkage (Figure 7—figure supplement
2d). We found that an arterial wall consisting solely of SMCs and uniform matrix maintained a mean
positive circumferential stress in the inner layer during contraction, that prevented buckling. Thus, a
delicate biomechanical balance exists – reduced inner layer volume allows a smaller radius to be
achieved via SMC contraction prior to buckling (Figure 7—figure supplement 2b), thus aiding clo-
sure, yet excess volume reduction of the inner layer increases the active stress requirement for buck-
ling and achieving complete vessel closure (Figure 7d). The umbilical artery can reduce its cylindrical
radius dramatically at Tact near a basal value of ~50 kPa, progressing to buckling and closure via a
subsequent near-maximal contraction (Figure 7e). In agreement with the computational modeling,
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Figure 4. Defective morphogenesis in Acan and Adamts1 mutant mouse umbilical cords. (a) H and E staining of E18.5 wild-type cords showing thicker
umbilical arterial (A) and thinner venous (V) wall (n = 6 umbilical cords). (b) Aggrecan and versican localization (red, DAPI counterstain blue) in E18.5
wild-type cords showing staining in the arterial inner tunica media (TM) and adventitia but not the vein (n = 3 umbilical cords). (c) b-gal (blue) and eosin
(red) staining of E18.5 Adamts1LacZ/+ (Adamts1+/-) cord showing strong Adamts1 expression in venous endothelium and TM and outer artery TM (n = 3
Figure 4 continued on next page
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20/25 of human umbilical arteries had 4 or more buckles, whereas those with no buckles in the area
analyzed by histology were patent (Figure 7f). Other large mammalian species analyzed showed a
similar phenomenon (Figure 7f). Thus, buckling of the proteoglycan-rich inner tunica media may be
a crucial and evolutionarily conserved mechanism employed by all mammals for rapid arterial occlu-
sion at birth.
Discussion
We report two distinct umbilical cord blood vessel specializations that may facilitate rapid umbilical
artery occlusion at birth: a distinct proteoglycan-rich inner arterial TM, generating a bilayered arterial
wall, and selective contraction of SMCs in the outer layer (Figure 8). The rounded SMCs of the inner
TM may be specialized for CSPG production rather than contraction, consistent with nuclear Sox9
staining, a function they exert prior to delivery. During delivery, lack of pMLC staining suggests that
despite differentiated SMC marker expression, the inner cells play a passive role. Biomechanical test-
ing and computational analysis confirm that selective proteoglycan enrichment in the inner arterial
TM ensures that contracting SMCs in the outer TM can effectively occlude the arterial lumen at birth
(Figure 8). Histologic and computational analysis showed buckling of the inner TM and fluid redirec-
tion into the resulting TM protrusions as critical mechanisms resulting from specialization of the inner
and outer arterial TM. By in silico simulations of umbilical arteries with modulation of the contractile
outer layer and proteoglycan-rich inner core, we demonstrate that complete occlusion can be
achieved.
Our work suggests that a principal mechanism governing umbilical cord vascular dimorphism
resides in extracellular matrix, namely, differentially regulated dynamics of aggrecan and versican,
which may then modulate SMC development and differentiation. Other mammalian umbilical vessels
examined, from animals as large as the walrus and elephant to as small as the mouse, showed similar
CSPG and aggrecan modulation as in humans. Although Vcan mutant mice die before umbilical cord
development is completed (Yamamura et al., 1997) and could not be studied, Acan and Adamts1
mutants demonstrated their mechanistic contributions to the observed dimorphism. Our emphasis
on aggrecan in the inner layer, with its abundant GAGs and their high fixed charge density, was rele-
vant to the computational findings of the importance of inner layer swelling and buckling in response
to SMC contraction. The umbilical vein contains fewer contractile SMCs and has scant aggrecan and
versican. Hence, SMC activation in the umbilical vein does not occlude the lumen to the same
degree as in the arteries, a contention supported by computational analysis. Given the evolutionary
pressure to achieve hemostasis urgently in the artery rather than the vein, these findings suggest a
highly evolved mechanism for preventing exsanguination of the newborn that is potentially relevant
to other embryonic shunts that occlude rapidly at birth.
The computational model was built on a long history of studying murine arteries and veins
(Ferruzzi et al., 2013), but was specialized to the GAG-rich inner layer and SMC-rich outer layer of
the umbilical artery. Modeling the dynamics of associated volume changes would have required a
mixture or poroelastic model and significantly more experimental data, including measurement of
layer-specific permeabilities and fixed-charge densities. Instead, we modeled the quasi-equilibrated
states using a well-accepted approach wherein the degree of swelling can be adjusted for each sim-
ulation (Demirkoparan and Pence, 2007; Szafron et al., 2017). Interestingly, prior results by others
Figure 4 continued
umbilical cords). (d) Short umbilical cords in E18.5 Adamts1-/- and Acan-/- embryos compared to wild type. Red arrowhead indicates an omphalocele in
Adamts1-/- embryos. (e) H & E staining of E18.5 wild type, Acan-/- and Adamts1-/- cord cross-sections showing thinner walls in Acan-/- umbilical vessels
and thicker walls in Adamts1-/- umbilical vessels. (f–g) Cord length, TM thickness and vessel luminal area quantifications for Adamts1-/- (f) and Acan-/-
mice (g) at E18.5 compared to wild-type littermates. Acan-/- umbilical cords show larger lumens and Adamts1-/- vessels show smaller lumens in (n = 7–
11 umbilical cords each, whiskers indicate minimum and maximum values, *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001). (h) Phospho-histone H3
(pHH3) staining shows significantly fewer proliferating cells (white arrowheads) in Acan-/- umbilical vessels. Dotted white lines mark the boundaries of
vessel lumens (n = 4 cords each, whiskers indicate minimum and maximum values, **, p<0.001; *, p<0.05). Scale bars = 100 mm in (a), 25 mm in (c), 100
mm and 50 mm in (e).
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. ADAMTS, Vcan and Acan expression and impact of aggrecan loss on early mouse umbilical cord and vessel development.
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Figure 5. Contrasting smooth muscle cell (SMC) phenotype modulation in Acan and Adamts1-deficient umbilical vessels. (a) Aggrecan (green) and a-
SMA staining (red) in E18.5 umbilical cords show loss of aggrecan and weak a-SMA staining in Acan-/- vessels (n = 3 umbilical cords each genotype). (b)
Smooth muscle myosin heavy chain (SMMHC, red) and phosphorylated myosin light chain (pMLC, green) staining in E18.5 umbilical cords showing
dramatic signal attenuation in the Acan-/- vessels (n = 3 umbilical cords each genotype) (c) pMLC (green), endomucin (red), a-SMA (red, center panels)
Figure 5 continued on next page
Nandadasa et al. eLife 2020;9:e60683. DOI: https://doi.org/10.7554/eLife.60683 11 of 30
Research article Computational and Systems Biology Developmental Biology
showed that swelling of an initially unloaded, unilayered cylindrical tube consisting of a neo-Hookean
material (which we used to model GAG-rich tissue) increases luminal diameter if the tube is uncon-
strained (Demirkoparan and Pence, 2007). The tube must be constrained, such as by a stiff outer
layer surrounding the swollen layer if swelling is to decrease luminal diameter (Szafron et al., 2017).
The abundance of contractile SMCs in the stiffer outer layer and their basal tone may in fact enhance
outer layer stiffness contributed by extracellular matrix and hence buckling appears to be essential
to augment contraction-induced closure of the umbilical artery (cf [Moulton and Goriely, 2011]).
This observed architecture of the umbilical cord is likely to have supported survival of mammalian
species, humans included, well before formal obstetric involvement in labor. Cord clamping is the
default practice today and has the sanction of convention, offering the option of immediate neonatal
resuscitation if needed. In regard to the umbilical artery, it would replicate the effect of a natural
and apparently conserved physiologic process that interrupts its blood flow during transition from
fetal to neonatal life. The latest recommendation to clamp the cord later rather than immediately
after birth appears to align better with the delayed closure of the umbilical vein. The present studies
Figure 5 continued
and SMMHC (red, right-hand panels) staining shows blunted dimorphism of Adamts1-/- umbilical artery and vein with stronger expression of
differentiated SMC markers in Adamts1-/- umbilical vessels and acquisition of endomucin, a venous endothelium marker, by arterial endothelium (n = 3
umbilical cords each genotype) Scale bars = 100 mm in (a–c).
Figure 6. Reduced aggrecan and versican proteolysis in Adamts1-/-umbilical vessels. (a,b) E17.5 Adamts1-/- umbilical vessels show increased aggrecan
staining and reduced anti-NITEGE staining in (a), quantified in (b) (n = 3 cords each genotype, error bars indicate mean ±S.D.*, p<0.05; **, p<0.01; ***,
p<0.001). (c,d) Adamts1-/- umbilical vessels show increased versican (c) and reduced anti-DPEAAE staining quantified in (d) (n = 3 cords each genotype,
error bars indicate mean ±S.D. *, p<0.05; **, p<0.01). Scale bars = 50 mm in (a–c).
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Figure 7. Contraction-induced buckling ensures effective closure of the umbilical artery at birth. (a) Smooth muscle myosin heavy chain (SMMHC-red)
and serine-20 phosphorylated myosin light-chain (pMLC-green) show more contraction-primed SMCs in the outer arterial tunica media (TM, white
brackets) than the umbilical vein. Scale bars are 100 mm. (b) Quantitation of pMLC+ SMCs in the artery (red) and vein (blue) (top, n = 5 arteries, four
veins, whiskers indicate minimum and maximum values, *, p<0.05) and inner and outer TM of both reveal similar distributions but more pMLC+ SMC in
Figure 7 continued on next page
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in humans and other mammals show that evolution has devised an umbilical cord-intrinsic mecha-
nism that facilitates rapid arterial occlusion at birth, leaving the vein patent and permitting a placen-
tal infusion. This unfailing sequence ensures continuation of mammalian species without other formal
intervention, since evolutionary success is not about minimizing poor outcomes, but ensuring survival
of a significant majority.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Gene
(Homo sapiens)
ACAN GenBank RRID:HGNC:319 Chondroitin sulphate
proteoglycan 1
Gene
(Homo sapiens)
VCAN GenBank RRID:HGNC:2464 Chondroitin sulphate
proteoglycan 2
Gene
(Homo sapiens)
ADAMTS1 GenBank RRID:HGNC:217 ADAM metallopeptidase
with thrombospondin
type 1 motif 1
Gene
(Homo sapiens)
ADAMTS4 GenBank RRID:HGNC:220 ADAM metallopeptidase
with thrombospondin
type 1 motif 4
Gene
(Homo sapiens)
ADAMTS5 GenBank RRID:HGNC:221 ADAM metallopeptidase
with thrombospondin
type 1 motif 5
Gene
(Homo sapiens)
ADAMTS9 GenBank RRID:HGNC:13202 ADAM metallopeptidase
with thrombospondin
type 1 motif 9
Genetic reagent
(Mus musculus)
Acancmd-Bc
(C57BL/6J background)
Krueger et al., 1999 RRID:MGI:1855999 Acan null allele
Genetic reagent
(Mus musculus)
Adamts1tm1Dgen
(C57BL/6J background)
Oller et al., 2017 RRID:MGI:5427602 Adamts1 null and
LacZ reporter allele
Antibody Mouse monoclonal smooth
muscle a-actin (a-SMA)
Cy3 conjugated
Millipore
Sigma C6198
RRID:AB_476856 IF (1:400)
Antibody Rat monoclonal smooth
muscle myosin heavy
chain (SMMHC)
Kamiya Biomedical
MC352
RRID:AB_1241986 IF (1:400)
Antibody Rabbit polyclonal
Serine-20 phosphorylated
myosin light chain (pMLC)
Abcam Ab2480 RRID:AB_303094 IF (1:200)
Continued on next page
Figure 7 continued
the outer artery TM (bottom, n = 3 arteries, four veins, error bars indicate mean ±S.D. *, p<0.05; **, p<0.01). (c) Differential contraction of murine
umbilical artery and vein stimulated by 100 mM potassium chloride (KCl) under biaxial loading confirms greater contractility in the artery, with OCT
images prior to and following contraction-induced arterial closure (n = 4 arteries and n = 4 veins). (d) Computational simulations of a bilayered artery
with contractile SMCs in the outer layer and swollen inner layer: critical contractile stress values leading to buckling for (left) different numbers of folds
for a normalized inner layer volume of 0.5 and (right) decreasing values of normalized volume of the inner layer for seven folds. (e) Normalized inner
radius as a function of contractile stress for inner layer volume change of 0.5 and 7 folds. The states for the inflection (square) and critical active stress
(star) are illustrated by the schematics; complete closure achieved with contraction-induced buckling. All simulations were run for 25 mmHg pressure.
Due to the linear stability analysis, the amplitude of the folds in the buckled schematics is illustrative. (f) Number of buckles observed in human (top,
indicated as umbilical cord (UC)1–25) and other large mammalian (bottom) umbilical arteries. Both arteries per cord were included. Open vessel lumens
are indicated where observed.
The online version of this article includes the following figure supplement(s) for figure 7:
Figure supplement 1. Differential biomechanical properties of arteries and veins of the mouse umbilical cord.
Figure supplement 2. Computational results for a model umbilical artery.
Nandadasa et al. eLife 2020;9:e60683. DOI: https://doi.org/10.7554/eLife.60683 14 of 30
Research article Computational and Systems Biology Developmental Biology
Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Antibody Rabbit polyclonal
anti-serine-10
phosphorylated
histone H3 (pHH3)
Millipore Sigma
06–570
RRID:AB_310177 IF (1:200)
Antibody Mouse monoclonal
anti-chondroitin sulfate
(7D4) antibody
Bruce Caterson/Clare
Hughes laboratory
(Sorrell et al., 1990)
RRID:AB_2864328 IF (1:200)
Antibody Mouse monoclonal FITC-
conjugated anti-heparan
sulfate (10E4) antibody
US Biological
H-1890
RRID:AB_10013601 IF (1:200)
Antibody Rabbit polyclonal
Anti-versican (pVC)
Apte laboratory
(Foulcer et al., 2014)
RRID:AB_2864327 IF (1:400) human tissue
Antibody Rabbit polyclonal anti-
versican GAG-beta
Millipore Sigma AB1033 RRID:AB_90462 IF (1:400) mouse tissue
Antibody Rabbit polyclonal anti-
versican V0/V1 neo
epitope DPEAAE
Invitrogen
PA1-1748A
RRID:AB_2304324 IF (1:200)
human/mouse
Antibody Rabbit polyclonal
anti-aggrecan
Millipore Sigma
AB1031
RRID:AB_90460 IF (1:400) all species
Antibody Rabbit polyclonal
anti-aggrecan neo
epitope NITEGE
Invitrogen
PA1-1746
RRID:AB_2242021 IF (1:200) all species
Antibody Rat monoclonal
anti-endomucin antibody
(clone eBioV.7C7)
Invitrogen
14-5851-85
RRID:AB_891531 IF (1:400)
Antibody Rabbit polyclonal
anti-SOX9 antibody
Millipore Sigma
AB5535
RRID:AB_2239761 IF (1:200)
Commercial
assay or kit
ACAN RNAscope
In situ probe
ACD bio 506841 Human probe
Commercial
assay or kit
Acan RNAscope
In situ probe
ACD bio 439101 Mouse probe
Commercial
assay or kit
VCAN-E8 RNAscope
In situ probe
ACD bio 452241 Human probe
detects exon 8
Commercial
assay or kit
Vcan-E8 RNAscope
In situ probe
ACD bio 428321 Mouse probe detects exon 7
Commercial
assay or kit
ADAMTS1 RNAscope
In situ probe
ACD bio 524501 Human probe
Commercial
assay or kit
Adamts1 RNAscope
In situ probe
ACD bio 463361 Mouse probe
Commercial
assay or kit
ADAMTS4 RNAscope
In situ probe
ACD bio 537341 Human probe
Commercial
assay or kit
Adamts4 RNAscope
In situ probe
ACD bio 497161 Mouse probe
Commercial
assay or kit
ADAMTS5 RNAscope
In situ probe
ACD bio 427611 Human probe
Commercial
assay or kit
Adamts5 RNAscope
In situ probe
ACD bio 427621 Mouse probe
Commercial
assay or kit
ADAMTS9 RNAscope
In situ probe
ACD bio 445321 Human probe
Commercial
assay or kit
Adamts9 RNAscope
In situ probe
ACD bio 400441 Mouse probe
Commercial
assay or kit
RNAscope 2.5 HD Red
In situ detection kit
ACD bio 322350 Used for detecting all
probes in this study
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Software,
algorithm
Affymetrix Transcriptome
Analysis Console,
RMA-SST sketch algorithm
Affymetrix
TAC 4.0
RRID:SCR_018718 Used for gene expression
analysis for all microarray
experiments in the study
Software,
algorithm
R Bell Laboratories/R Foundation for
Statistical Computing
Ver. 3.5.2.
RRID:SCR_001905 Used for statistical
computing
of microarray data
Software,
algorithm
GraphPad Prism GraphPad RRID:SCR_002798 Used for statistical
computing of other
experimental data
Abbreviations, IF, Immunofluorescence.
Human and large mammal cords
Twenty-five human umbilical cords were obtained from uncomplicated term pregnancies either after
vaginal birth (n = 13) or Cesarean section for obstetric indications (n = 12), that is, malpresentation
or repeat Cesarean section. The samples were collected under an IRB exemption from Cleveland
Clinic (EX-0118) for use of discarded tissue without patient identifiers. These cords were used for his-
tological/immunohistologic analysis, synchrotron imaging, RNA in situ hybridization, and transcrip-
tomics of inner versus outer umbilical artery TM. Animal cord sections were provided by Disease
Investigations, Institute for Conservation Research, San Diego Zoo Global from the Benirschke
archive.
Mutant mice
The Adamts1 transgenic allele (Adamts1tm1Dgen), referred to herein as Adamts1-/-, was produced by
insertion of an IRES-lacZ cassette into intron 1 of Adamts1 using homologous recombination in
mouse embryonic stem cells (Oller et al., 2017). The Acancmd-Bc allele was previously described
(Krueger et al., 1999) and is referred to herein as Acan-/-. Mice were handled under standard condi-
tions under approved IACUC protocols at the Cleveland Clinic (IACUC protocol nos. 18–1996 and
18–2045) and University of Chicago (IACUC protocol no. 43751). Mutant mouse embryos were col-
lected by timed matings of heterozygous mice by the detection of copulation plugs (taken as day
0.5 of gestation). Embryos were dissected out immediately following CO2 mediated euthanasia and
cervical dislocation of pregnant mice. Dissected whole embryos, with umbilical cords and placentas
attached, were fixed in 4% paraformaldehyde at 4˚C overnight. Umbilical cords were dissected out
the following day and washed thrice in PBS and embedded in paraffin or in 4% agarose for vibra-
tome sectioning as previously described (Nandadasa et al., 2015).
Table 1. Model parameters fixed for all simulations of the umbilical artery, determined primarily
from the biaxial biomechanical data and histological findings.
Parameters Description Values
A; B; C Unloaded inner, interface, outer radius 161.77, 206.86, 236.92 mm
lz Loaded axial stretch 1.28
1; 2 GAG/matrix shear modulus inner, outer layer 3.0 kPa, 0.1 kPa
c1
1
; c1
2
Axial fiber family material parameters 0.013 kPa, 11.65
c2
1
; c2
2
Circumferential fiber family material parameters 2.66 kPa, 1.20
c
3;4
1
; c3;4
2
Diagonal fiber families’ material parameters 3.04 kPa, 4.23
h3;h4 Diagonal fiber families’ alignment parameter 41.92˚,  41.92˚
lm; l0 Maximum, minimum contractile stretch 2.5, 0.2
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Biomechanical and computational analysis
The umbilical artery and vein were obtained at E18.5 from mouse embryos (n = 4) following approval
by the Yale University IACUC (protocol no 2018–11508), then mounted within a custom computer-
controlled biaxial device designed specifically for biomechanical testing of murine vessels
(Gleason et al., 2004). Vessel maintenance, pre-conditioning, biaxial loading protocols and data col-
lection are described in Appendix 1. The umbilical artery was modeled computationally as a thick-
walled, bilayered cylindrical tube subjected to swelling of the GAG-rich inner layer and active
Figure 8. The unique bilayered design of the umbilical artery underlies its rapid occlusion at birth. (a) Differential expression of ADAMTS proteases and
large CS-proteoglycans during development results in a bilayered artery with a hydrated proteoglycan-rich inner layer and most contractile SMCs
located in the outer layer, contrasting with the umbilical vein (see key at top of figure identifying the illustrated major elements). (b) At birth, SMC
contraction in the outer layer and fluid movement-induced inner layer buckling redirects the inner layer into the lumen. The single-layered vein does
not undergo buckling. (c) Umbilical artery occlusion at birth prevents neonatal exsanguination, whereas the patent vein allows a final transfusion from
the placenta.
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contraction of the smooth muscle-rich outer layer; the model also included a passive contribution of
extracellular matrix as revealed by biomechanical tests.
Statistical analysis
Statistical analyses were carried out using GraphPad Prism analytical software (versions 6–8, Graph-
Pad, San Diego, CA) in determining statistical significance using two-tailed Student’s t-test. Statisti-
cal details including N and p values are provided in each corresponding figure legend. Statistical
analyses for microarray gene expression were performed using Affymetrix’s Transcriptome Analysis
Console (TAC 4.0) through the RMA-SST sketch algorithm and R version 3.5.2. Fold changes were
calculated by an empirical Bayes ANOVA method through the TAC 4.0 software. Details of these
and additional methods are provided in Appendix 1.
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Appendix 1
Detailed methods
Human tissue
After delivery of the neonate, the umbilical cord was doubly clamped and cut. The time from deliv-
ery to cord clamping varied between deliveries and in general ranged from 5 to 30 s. Two additional
clamps were placed on the cord after a fetal blood sample was obtained for Rhesus typing, and scis-
sors were used to cut between these two clamps to obtain a segment of umbilical cord for analysis.
Umbilical cord samples were fixed in 4% paraformaldehyde for 48 hr at 4˚C and embedded in paraf-
fin. All human umbilical cord sections analyzed contained all three vessels and both arteries were
imaged in addition to the vein. For microarray analysis of umbilical artery versus vein, human umbili-
cal cords were separately collected as a part of the National Children’s Study (NCS) (UHCMC IRB#
01-11-28). Immediately upon delivery, cords were sectioned into 1-inch segments (for a total of 3
segments per cord at 0 hr) and flash frozen in liquid nitrogen. RNA Later-ICE (Ambion) was used to
maintain nucleic acid viability during freeze-thaw of tissue. The umbilical vein and both umbilical
arteries were dissected from each segment for homogenization. RNA from homogenized vein and
artery tissue was extracted using Qiagen’s RNeasy nucleic acid isolation kit. For microarray analysis
of the inner versus outer arterial tunica media, human umbilical arteries were dissected immediately
upon neonatal delivery and sectioned into 1-inch segments (for a total of three segments per artery)
and their inner and outer tunica media were carefully dissected under a dissecting microscope and
flash frozen in liquid nitrogen in Trizol reagent (Ambion). RNA from homogenized arteries was
extracted using the chloroform-isopropanol precipitation method.
Histological and immuno-staining
Seven-micron-thick paraffin sections were collected using a Leica RM 2255 microtome and stained
with hematoxylin and eosin, Alcian blue, or Masson’s trichrome after deparaffinization. For immunos-
taining, sections were deparaffinized, and boiled in citrate buffer (10 mM citric acid, 0.05% Tween
20, pH 6.0) for 90 s for antigen retrieval, washed with PBST and blocked in 10% normal goat serum
before incubation with the following primary antibodies overnight at 4˚C: Cy3-conjugated smooth
muscle a-actin (a-SMA) (1:400, Sigma C6198), anti-smooth muscle myosin heavy chain (SMMHC)
(1:400 Kamiya Biomedical, MC352), anti-serine20-phosphorylated myosin light chain (pMLC) (Abcam,
ab2480 1:200), anti-phospho histone H3 (ser10)(1:200, Millipore, 06–570), anti-chondroitin sulfate
(7D4) antibody (Sorrell et al., 1990) (1:200), FITC-conjugated anti-heparan sulfate (10E4) antibody
(1:200, US biological H-1890), polyclonal anti-versican (Foulcer et al., 2014) (anti-VC; 1:400), poly-
clonal anti-versican GAG-b (1:400, Milipore Sigma, AB1033), anti- DPEAAE (versican V0/V1 neo epi-
tope antibody, 1:200, Invitrogen, PA1-1748A), polyclonal anti-aggrecan (1:400, Milipore Sigma,
AB1031), anti- NITEGE (aggrecan neo epitope antibody, 1:200, Invitrogen, PA1-1746), rat monoclo-
nal anti-endomucin (1:400, Invitrogen, 14-5851-85), anti-Sox9 (1:200, Milipore Sigma Ab5535).
Alexa-488 or Alexa-568 conjugated secondary antibodies against rabbit and mouse IgG, respec-
tively, were used at 1:400 dilution. Vectashield mounting medium (H-1200) contained DAPI for stain-
ing nuclei. All images were taken using an Olympus BX51 microscope connected to a Leica DFC
7000T camera using bright field or fluorescence modes. Multi-channel fluorescent images were
merged using the NIH Image J software.
Synchrotron-based phase contrast micro-CT
Imaging of arteries and veins from three umbilical cords was performed at the X02DA TOMCAT
beamline of the Swiss Light Source at the Paul Scherrer Institute (Villigen, Switzerland). A 4x magnify-
ing objective was used, resulting in a field-of-view of 4.2  3.5 mm2 and an effective pixel size of
1.63  1.63 mm2. For each scanned vessel, a stack of 1080 tomographic images was acquired. Data
analysis was performed using NIH Image J and Amira. Amira allowed for visualization of the vessels
from any angle and images were created by combining two different tomographic imaging planes at
a 90-degree angle. NIH Image J was used for creating Figure 1—videos 1 and 2.
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Microarray analysis of human umbilical cords
NCS samples to evaluate changes in expression in artery versus vein were run on the Affymetrix Hu-
Gene U219 microarray Peg-plate; 150 ng of input RNA from each sample was labeled using an Affy-
metrix 3’ IVT labeling protocol. Samples hybridized to the PEG arrays were washed, stained, and
scanned by the Affymetrix Gene Titan. RNA from two of the four cords was also evaluated on the
Affymetrix Hu-Gene 1.1 ST Peg-plate microarray, using the whole transcriptome (WT) labeling proto-
col also starting with 150 ng of input total RNA. The hybridized PEG Arrays were washed, stained,
and scanned by the Affymetrix Gene Titan according to standard protocols. RNA (150 ng) from inner
and outer TM samples was labeled using Affymetrix’s WT PLUS protocol. Labeled samples were
hybridized overnight to Affymetrix Hu-Gene 2.0 ST microarray cartridges. The sample was removed,
then the microarray cartridges were washed and stained on the Affymetrix GeneChip Fluidics Sta-
tion450 and scanned by the Affymetrix GeneChip Scanner 3000. Total RNA was labeled using Affy-
metrix’s FLASH Tag Protocol. Labeled samples were hybridized overnight to Affymetrix GeneChip
miRNA 2.0 Array, which interrogates all the mature human miRNA sequences in miRBase Release
20microRNAs. The sample was then removed and the microarray cartridges were washed and
stained on the Affymetrix GeneChip Fluidics Station450 and scanned by the Affymetrix GeneChip
Scanner 3000. Gene expression analysis for each microarray study was performed using Affymetrix’s
Transcriptome Analysis Console (TAC 4.0) through the RMA-SST sketch algorithm and R version
3.5.2. Fold changes were calculated by an empirical Bayes ANOVA method through the TAC 4.0
software. Parameters for gene expression changes include a p-value0.05 and a fold change
value 1.5 and 1.5. Data collected from samples labeled by different labeling protocols, obtained
using different scanners or hybridized to different arrays were analyzed as independent data sets.
Additional details of transgenic mice
The Adamts1 transgenic allele used here (referred to as Adamts1-) was generated by Deltagen Inc
(San Carlos, CA; Deltagen identifier T1288; MGI:5427602 (B6;129P2-Adamts1 < tm1Dgen>/H;)) by
inserting an IRES-lacZ-neomycin resistance gene cassette into intron 1. RT-PCR using PCR primers
bridging exon 1 and exon two showed that the insertion eliminated gene expression (Deltagen,
unpublished data). The allele was deposited in the MRC Harwell, Frozen Embryo and Sperm Archive
(Harwell, UK). Frozen Adamts1+/- embryos harvested at the two-cell stage of development from mat-
ings of wild-type C57BL/6 females with hemizygous males at MRC Harwell were obtained under an
academic use license signed by the Cleveland Clinic with Deltagen. Frozen embryos were implanted
into pseudo-pregnant female recipient mice at the Case Transgenic and Targeting Facility (Cleve-
land, OH). Subsequently, the Adamts1- allele was crossed into the C57BL/6 strain for at least 10 gen-
erations and is maintained in this strain. The Acancmd-Bc allele (referred to here as Acan+/-) was back-
crossed to C57BL/6 for over 20 generations at the University of Chicago (Lauing et al., 2014) and
subsequently transferred to the Cleveland Clinic Lerner Research Institute. b-Galactosidase staining
of Adamts1+/- umbilical cords was done as previously described (McCulloch et al., 2009). Both b-
galactosidase staining and genotyping were used to identify Adamts1+/- mice obtained from hemizy-
gous with wild-type matings, whereas PCR genotyping was used to distinguish the three genotypes
possibly arising from crosses of Adamts1 or Acan hemizygous animals which were used to generate
homozygous embryos.
For genotyping, genomic DNA was isolated from clipped toes between 7–10 days after birth or
from embryo tails using 100 ml or 50 ml Direct PCR Tail Lysis reagent, respectively (Viagen, catalog
number 102 T) containing 1 ml of proteinase K (Milipore Sigma, catalog number 3115879001) fol-
lowed by digestion overnight at 55˚C. Alternatively, tail DNA was extracted using QuickExtract DNA
(Lucigen) at 65˚C for 15 min and reaction was stopped by incubation at 100˚C for 5 min.
The targeted Adamts1 allele was detected by PCR using forward primer 5’ GGGCCAGCTCA
TTCCTCCCACTCAT 3’ and reverse primer 5’GCCATCGGGGTCAGCTTTTCAAATG 3’ (generating a
356 bp product) and the wild-type Adamts1 allele was detected using forward primer 5’ GGTTG
TAGTTTCGCGCTGAGTTTTG3’ and reverse primer 5’GCCATCGGGGTCAGCTTTTCAAATG 3’ (gen-
erating a 189 bp product). Acan genotyping was performed using the following primer pairs:
Acancmd forward primer 5’ ATCAAGACCCTCAGCTTTTATTAATCTTTA 3’ and reverse primer 5’ CA
TAAGATGAGAGGAGATGGTTTAGAGTAT 3’ (expected product 811 bp); Acan wild type allele
Nandadasa et al. eLife 2020;9:e60683. DOI: https://doi.org/10.7554/eLife.60683 24 of 30
Research article Computational and Systems Biology Developmental Biology
forward primer 5’ TCCTATTTACACAAAGTCTGAAATTAATGC 3’ and reverse primer 5’ GAGAA
TTGGCTATAGCTGTTTATGACTC 3’ (expected product 332 bp).
RNA in situ hybridization
Six-micron-thick paraffin sections were probed with RNAscope probes according to manufacturer’s
guidelines. The following probes were used: ACAN (Advanced Cell Diagnostics (ACD) Cat. No.
506841), VCAN-exon 8 (ACD Cat. No. 452241), ADAMTS1 (ACD Cat. No. 524501), ADAMTS4 (ACD
Cat. No. 537341), ADAMTS5 (ACD Cat. No. 427611), ADAMTS9 (ACD Cat. No. 445321), Acan (ACD
Cat. No. 439101), Vcan-exon 8 (ACD Cat. No. 428321), Adamts1 (ACD Cat. No. 463361), Adamts4
(ACD Cat. No. 497161), Adamts5 (ACD Cat. No. 427621) and Adamts9 (ACD Cat. No. 400441). The
probes were detected using RNAscope 2.5 HD Red reagent kits (ACD Cat. No. 322350) essentially
as recently described (Mead and Apte, 2020).
Biomechanical characterization of mouse umbilical arteries and veins
Umbilical cords were excised and separated from the placenta from wild-type C57BL/6J mice at
embryonic day E18.5 (n = 4). The umbilical arteries and veins were identified by opening the abdo-
men of the embryo and locating an artery by its connection to the iliac artery and a vein by its con-
nection to the inferior vena cava through the ductus venosus. After separating and cleaning the
umbilical arteries and veins from excessive adipose tissue, the intact vessels were cannulated on cus-
tom-drawn glass micropipettes, secured with silk sutures at each end, and mounted within a custom
computer-controlled biaxial test device designed specifically for testing murine vessels. These cylin-
drical specimens were then immersed in a Krebs-Ringer bicarbonate solution (Krebs) and oxygen-
ated with 95% O2 and 5% CO2 while maintained at 37˚C. The lumen of the umbilical artery closed
immediately after separating the umbilical cord from the placenta but was relaxed by acclimation
within the testing chamber for 5–15 min at 10 mmHg and wash-out with Krebs solution up to three
times. The vessels were then subjected to two isobaric (luminal pressure of 5 mmHg, then 10
mmHg) - axially isometric (fixed specimen-specific in vivo axial stretch) contractions by adding 100
mM KCl to the bath to ensure viability of the SMC. The transmural organization of the vessel wall
was monitored during different stages of contraction using an optical coherence tomography (OCT)
system having an axial (depth) resolution <7 microns and lateral resolution of 8 microns (Callisto
Model, Thorlabs, Newton, NJ).
For the subsequent passive tests, the normal Krebs solution was replaced with a Ca2+-free Krebs
solution. The vessels were preconditioned via four cycles of pressurization (artery: 0–40 mmHg and
vein: 0–25 mmHg) while held fixed at their individual in vivo axial stretch. Subsequently, the vessels
were subjected to a series of seven biaxial testing protocols: cyclic pressurization over ranges noted
above at three different fixed values of axial stretch and cyclic axial stretching at four different fixed
values of luminal pressure (artery at 10, 20, 30 or 40 mmHg and vein at 1, 2, 10 or 20 mmHg). Data
collected online included outer diameter, luminal pressure, axial length, and axial force, which facili-
tated robust parameter estimation of the biaxial biomechanical behavior (Ferruzzi et al., 2015).
Toward this end, we used a validated ‘four-fiber family’ type constitutive relation (see below) that
has proved useful in characterizing murine arteries (systemic and pulmonary) and veins.
Note that these biaxial data were used to build a baseline, bilayered cylindrical model for the pur-
poses of parametrically exploring possible effects of different levels of smooth muscle contractility in
the outer tunica media, GAG-induced swelling of the inner tunica media, and possible buckling of
this innermost layer in silico. Hence, rather than focus on specimen-to-specimen differences, we
sought ‘mean’ properties of the normal murine umbilical artery. Data from all seven passive biaxial
testing protocols from all four mice were grouped as a single data set and best-fit values of the asso-
ciated eight material parameters were determined simultaneously by minimizing the sum-of-the-
squares differences between predicted and measured pressures and axial forces, as described previ-
ously (Ferruzzi et al., 2015). To facilitate a global, rather than local, minimization, we used multiple
randomly generated initial guesses for the parameter estimation, accomplished using the MATLAB
routine (lsqnonlin function). It is important to note that best-fit parameters in exponential constitu-
tive relations need not be unique, hence what is most important is that together they yield correct
values of biaxial stress (verified by comparison to measured values) and predict appropriate levels of
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material stiffness and stored energy. Finally, it is noted that initial parameter estimation was based
on data from a representative specimen rather than all data combined; the subsequent model simu-
lations were similar in both cases, suggesting that the baseline model captured salient features as
desired.
Computational modeling of the umbilical artery
Swelling and contraction
The traction-free, non-swollen configuration R;Q; Zð Þ is treated as the reference with inner radius,
interfacial radius, and outer radius denoted A; B;C½ , respectively. Swelling is accounted for via pre-
viously outlined methods (Szafron et al., 2017; Demirkoparan and Pence, 2007), which leads to a
residually stressed, traction-free configuration with corresponding material points mapped to
A; B;C½  in R;Q; Zð Þ. The final loaded configuration, pressurized and axially stretched, is then
characterized by a; b; c½  in r; ; zð Þ.
Consider a deformation from R;Q; Zð Þ to R;Q; Zð Þ via the deformation gradient tensor
F
 ¼ diag qR=qR;R=R;Lz
  
, where volume change is imposed by detF ¼ n ¼ v=V with n the ratio
of volume v in R;Q; Zð Þ to volume V in R;Q; Zð Þ. With n ¼ 1, there is no swelling and the vessel is
considered to have no residual stresses; in contrast, n>1 (expansion) and n<1 (shrinkage) yields
self-equilibrating wall stresses in the absence of external loading. Note that qR=qR ¼ Rn=LzR
. Fur-
ther deformation to any loaded configuration r; ; zð Þ from the swollen configuration R;Q; Zð Þ is
then described by FP ¼ diag qr=qR; r=R; Lzð Þ, where the assumption of incompressibility during
transient external loading requires detFP ¼ 1, thus qr=qR ¼ R= Lzrð Þ. A multiplicative decomposition
of the deformations yields F ¼ FPF ¼ diag Rn=lzr; r=Rð , lz) with lz ¼ L

zLz for convenience. The
matrix component F11 can also be expressed in terms of the original derivatives, such that
qr=qRð Þ qR=qRð Þ ¼ Rlzn
=r, which allows us to apply the chain rule and integrate
R r
a
rqr ¼
R R
A
nR=lzqR to find any radial point r within the vessel wall.
The vessel is assumed to be quasi-equilibrated in any state, such that linear momentum balance
requires div t ¼ 0, where t is the Cauchy stress tensor. Circumferential and axial equilibrium is satis-
fied identically at each r; ; zð Þ. Radial equilibrium requires qtrr=qRþ trr   tð Þ=r ¼ 0. The Cauchy
stress is specialized as t ¼ tex   pI with p the Lagrange multiplier enforcing incompressibility during
transient loading, I the identity tensor, and tex the ’extra’ part of the stress due to deformation and
the constitutive response. Integration yields
P¼
Z b
a
tex  t
ex
rr
  
=rdrþ
Z c
b
tex  t
ex
rr
  
=rdr
where P is the transmural pressure across the vessel wall, with P>0 indicating internal pressurization.
We also calculate the overall axial load required for overall equilibrium,
L¼p
Z b
a
2texzz   t
ex
  t
ex
rr
  
rdrþp
Z c
b
2texzz   t
ex
  t
ex
rr
  
rdrþPpa2
See Figure 7d. The equilibrium problem is solved iteratively for the loaded inner radius a for each
luminal pressure P and axial extension lz.
Constitutively, the extra part of the Cauchy stress can be computed from a stored energy density
function W for the vessel, with t ¼ 2F qW=qCð ÞFT=detF  pI and C ¼ FTF the right Cauchy-Green
tensor. Due to the microstructure of the umbilical vessels, the GAG-rich inner layer is modeled as a
neo-Hookean matrix that can swell (Demirkoparan and Pence, 2007), with
W ¼
1
2
tr Cð Þ  3n
2
3
 
8 r<b;
with 1 a shear modulus for this inner layer. As there is no evidence of collagen with a preferred ori-
entation or smooth muscle cells capable of contraction within the inner layer, it is considered isotro-
pic and passive. Fewer GAGs are present in the outer layer, but we include the possibility of a
swellable matrix for illustrative purposes and to provide radial stiffness. The outer layer is then mod-
eled using a modified four-fiber family model for a passive nonlinear stress-stretch behavior and a
Rachev-type model for SMC contractility (i.e. active behavior), with a potential function
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W ¼ 2
2
tr Cð Þ  3n
2
3
 
þ
P
4
a¼1
ca
1
4ca
2
exp ca
2
la
2
  1
 
2
 
  1
 
þTact lþ
1
3
lm lð Þ
3
lm l0ð Þ
2
 
8 r>b
where 2 is shear modulus for the outer layer, c
a
1
and ca
2
are material parameters for each fiber family
a¼ 1;2;3;4, la ¼ sqrt C:Ma
N
M
að ), Tact is the magnitude of the active stress, lm is the stretch at
which contraction is maximum, and l0 is the stretch at which contraction ceases (Baek et al., 2007).
Each fiber family has an orientation vector Ma ¼ sin hað ÞeQþ cos h
að ÞeZ with h
a the fiber angle relative
to the axial direction. The fiber families are assumed to lie in the circumferential direction
(a¼ 1; h1 ¼ 90

), the axial direction (a¼ 2; h2 ¼ 0

), and symmetric diagonal directions about the z-
axis with ha fit from the experimental data (a¼ 3; h3 ¼ hd and a¼ 4; h4 ¼ hd). Parameter values are
given in Table 1 based on the aforementioned nonlinear least squares approach (Ferruzzi et al.,
2013).
Bifurcation analysis – basic approach
To examine the potential for unstable equilibria (i.e. bifurcations in the solutions) leading to buckling
of the wall, consider an incremental deformation added to the finite deformation (Ogden, 1984)
with a notation similar to that previously used to describe bifurcation behaviors in growing elastic
solids (Li et al., 2011; Moulton and Goriely, 2011), which is mathematically similar to swelling.
Quantities related to the intermediate finite deformation are given as ð Þ 0ð Þ while those related to the
incremental motions are denoted as ð Þ 1ð Þ. The current position x from position x 0ð Þ is specified as x ¼
x 0ð Þ þ u 1ð Þ with   1 scaling the displacement u 1ð Þ, which allows the deformation gradient to be
written as F ¼ F 0ð Þ þ H 1ð ÞF 0ð Þ with F 0ð Þ ¼ FPF the deformation gradient from the reference to the
finitely deformed configuration and H 1ð Þ the incremental displacement gradient with respect to that
configuration. The nominal stress P, defined through t ¼ FP=detF, follows as P ¼ P 0ð Þ þ P 1ð Þ. As
noted previously (Haughton and Ogden, 1978; Sanft et al., 2019), it is convenient to update the
reference configuration to the current configuration yielding P0 ¼ P
0ð Þ
0
þ P
1ð Þ
0
, which, along with con-
sidering the Lagrange multiplier as p ¼ p 0ð Þ þ p 1ð Þ, allows us to write P
1ð Þ
0
¼ B:H 1ð Þ þ p 0ð ÞH 1ð Þ   p 1ð ÞI
with B ¼ F 0ð Þ q2W=qF 0ð ÞqF 0ð Þ
  
F
0ð Þ the fourth-order stiffness tensor calculated in the finitely deformed
configuration and p 1ð Þ the increment in the Lagrange multiplier. Linear momentum balance then
requires divP0 ¼ 0, which is satisfied by the finite deformation, leaving divP
1ð Þ
0
¼ 0 to be resolved.
We proceed by assuming a form for the incremental displacement describing buckling as
u 1ð Þ ¼ u r; ð Þ; v r; ð Þ; 0½ , with no incremental motion in the axial direction. Displacements in the r and
 directions are not a function of z. The incremental displacement gradient then becomes
H
1ð Þ ¼
ur
u v
r
0
vr
uþv
r
0
0 0 0
2
4
3
5;
where ð Þr q ð Þ=qr and ð Þ q ð Þ=q. The incremental deformation is assumed to be isochoric, requir-
ing tr H 1ð Þ
  
¼ 0. As there is no axial dependence in the incremental deformation, the equilibrium
equations reduce to a system of two differential equations in u, v, and p 1ð Þ. These functions are
assumed to have sinusoidal forms in the buckled configuration, where u¼ f rð Þcos nð Þ,
v¼ g rð Þ sin nð Þ, and p 1ð Þ ¼ h rð Þcos nð Þ with n the buckling mode (i.e. the number of folds in the inner
portion of the vessel wall). Using the incompressibility condition, it is possible to rewrite g rð Þ in terms
of f rð Þ, and the two equilibrium equations can be combined to eliminate h rð Þ, yielding a single fourth
order, ordinary differential equation in f rð Þ (Haughton and Ogden, 1978; Sanft et al., 2019) of the
form
A4f
0000
þA3f
000
þA2f
00
þA1f
0
þA0f ¼ 0;
where coefficients A0-A4 are given below and ð Þ
0
¼ d ð Þ=dr. We assume that the incremental tractions
on the inner surface are zero with n  t 1ð Þ ¼ 0, which yields two equations
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B1;3f
000
þB1;2f
00
þB1;1f
0
þB1;0f ¼ 0
h i
r¼a
and B2;2f
00
þB2;1f
0
þB2;0f ¼ 0
h i
r¼a
;
with coefficients Bn;m given below. As there is little evidence of buckling in the outer layer, and the
Rachev-type contractility model generally yields tensile stresses that would inhibit buckling, we spec-
ify that the incremental deformation vanishes at the interface of the two layers with f bð Þ ¼ 0 and
f
0
bð Þ ¼ 0 and that the incremental shear traction is zero (Yang et al., 2007), which gives
C1;2f
00
þC1;1f
0
¼ 0
h i
r¼b
and C2;2f
00
þC2;0f ¼ 0
h i
r¼b
;
with coefficients Cn;m given below.
We used the compound matrix method (Haughton and Orr, 1997; Lindsay and Rooney, 1992),
a modification of the determinantal method commonly used for linear bifurcation analysis
(Haughton and Ogden, 1979), to solve the differential equation numerically. The fourth order equa-
tion above was rewritten as a system of four, first order differential equations, y0 ¼ Ay, where y ¼
f ; f
0
; f
00
; f
000 T
and A is the corresponding coefficient matrix. Boundary conditions at the inner surface
and interface were similarly re-written as By ¼ 0½ a and Cy ¼ 0½ b, respectively. We define two linearly
independent initial conditions at r ¼ a, which can be integrated to r ¼ b to create linearly indepen-
dent solutions y 1ð Þ and y 2ð Þ such that y ¼ k1y
1ð Þ þ k2y
2ð Þ ¼ Mk. For the determinantal method, one iter-
ates on Tact until det CM½ b
  
¼ 0: However, this method can fail for stiff systems, thus we use Laplace
expansions to write a new bifurcation condition equivalent to the original with det CMð Þ ¼
k
X
jCkjfk
where
f1 ¼
y
1ð Þ
1
y
2ð Þ
1
y
1ð Þ
2
y
2ð Þ
2










¼ 1;2ð Þ; f2 ¼
y
1ð Þ
1
y
2ð Þ
1
y
1ð Þ
3
y
2ð Þ
3










¼ 1;3ð Þ;
and similarly, f3 ¼ 1;4ð Þ, f4 ¼ 2;3ð Þ, f5 ¼ 2;4ð Þ, f6 ¼ 3;4ð Þ. We evaluate Ck ¼ jCkj with
C1 ¼
C1;1 C2;1
C1;2 C2;2








¼ 1;2ð Þ; C2 ¼
C1;1 C2;1
C1;3 C2;3








¼ 1;3ð Þ;
and similarly, C3 ¼ 1;4ð Þ, C4 ¼ 2;3ð Þ, C5 ¼ 2;4ð Þ, C6 ¼ 3;4ð Þ, where
n;mð Þ 
C1;n C2;n
C1;m C2;m








:
To evaluate the new bifurcation condition, we create a system of equations f0 ¼Af and identify
the components of f0 as, for example,
f
0
1
¼
y
1ð Þ
1
0
y
2ð Þ
1
0
y
1ð Þ
2
y
2ð Þ
2










þ
y
1ð Þ
1
y
2ð Þ
1
y
1ð Þ
2
0
y
2ð Þ
2
0










¼
P
4
i A1iy
1ð Þ
i
P
4
i A1iy
2ð Þ
i
y
1ð Þ
2
y
2ð Þ
2










þ
y
1ð Þ
1
y
2ð Þ
1
P
4
i A2iy
1ð Þ
i
P
4
i A2iy
2ð Þ
i










:
The components of A can thus be conveniently defined in terms of the original components of A
(Haughton and Orr, 1997), as listed below. This new system is then integrated from a to b using a
fourth-order Runge-Kutta method, and Tact is varied iteratively until the boundary condition at b is
satisfied, namely
k
X
Ckfk
 
b
¼ 0. Loading conditions, including the volume change n, luminal pres-
sure P, and axial stretch lz, can be varied parametrically to understand their effects on the critical
value of Tact needed to induce buckling. Note, one may also fix the value of Tact and identify the crit-
ical value of a different loading variable of interest.
Bifurcation analysis – specific functions
For the fourth order governing differential equation for the incremental displacement:
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A4f
0000
þA3f
000
þA2f
00
þA1f
0
þA0f ¼ 0
we have
A0 ¼ n
2   1ð Þ r2B
00
rr þ rB
0
rr þ n
2   1ð Þ Brr þ n
2 B  Brrrrð Þ
 
A1 ¼ r r
2B
00
rr þ rB
0
rr  Brr   n
2 B þBrrrrð Þ
 
  n2r B0 þB
0
rrrrð Þ
 
A2 ¼ r
2 r2B
00
rr þ 7rB
0
rr þ 5Brr   n
2 B þBrrrrð Þ
 
A3 ¼ r
3
2rB
0
rr þ 6Brr
 
A4 ¼ r
4Brr
Note: These coefficients include only the non-zero components of B for the considered stored
energy density function.
For the fourth order differential equation
y0 ¼Ay
note that
A¼
0 1 0 0
0 0 1 0
0 0 0 1
 A0=A4  A1=A4  A2=A4  A3=A4
2
6
6
4
3
7
7
5
For boundary conditions on the governing equation at the inner surface:
B1;3f
000
þB1;2f
00
þB1;1f
0
þB1;0f ¼ 0
h i
r¼a
we have,
B1;0 ¼ n
2   1ð Þ rB
0
rr þBrr
 
B1;1 ¼ r rB
0
rr   n
2   1ð ÞBrr   n
2 B þBrrrrð Þ
 
B1;2 ¼ r
2 rB
0
rr þ 4Brr
 
B1;3 ¼ r
3Brr
B2;0 ¼ Brr n
2   1ð Þ
B2;1 ¼ Brr r
B2;2 ¼ Brr r
2
B2;3 ¼ 0
For boundary conditions on the governing equation at the interface:
C1;2f
00
þC1;1f
0
¼ 0
h i
r¼b
we have
C1;0 ¼ 0
C1;1 ¼ Brr r
C1;2 ¼ Brr r
2
C1;3 ¼ 0
C2;0 ¼ Brr n
2   1ð Þ
C2;1 ¼ 0
C2;2 ¼ Brr r
2
C2;3 ¼ 0
Finally, for the compound matrix method component matrix
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A¼
A11þA22 A23 A24  A13  A14 0
A32 A11þA33 A34 A12 0  A14
A42 A43 A11þA44 0 A12 A13
 A31 A21 0 A22þA33 A34  A24
 A41 0 A21 A43 A22þA44 A23
0  A41 A31  A42 A32 A33þA44
2
6
6
6
6
6
6
4
3
7
7
7
7
7
7
5
with the components of A given above.
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